Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126


Modulation of peripheral B cell tolerance by CD72 in a murine model.

Li DH, Winslow MM, Cao TM, Chen AH, Davis CR, Mellins ED, Utz PJ, Crabtree GR, Parnes JR.

Arthritis Rheum. 2008 Oct;58(10):3192-204. doi: 10.1002/art.23812.


CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes.

Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF.

J Exp Med. 1997 Dec 1;186(11):1923-31.


Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.

Xu M, Hou R, Sato-Hayashizaki A, Man R, Zhu C, Wakabayashi C, Hirose S, Adachi T, Tsubata T.

J Immunol. 2013 Jun 1;190(11):5436-45. doi: 10.4049/jimmunol.1203576. Epub 2013 Apr 24.


CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytes.

Li DH, Tung JW, Tarner IH, Snow AL, Yukinari T, Ngernmaneepothong R, Martinez OM, Parnes JR.

J Immunol. 2006 May 1;176(9):5321-8.


CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Wu HJ, Bondada S.

J Clin Immunol. 2009 Jan;29(1):12-21. doi: 10.1007/s10875-008-9264-6. Epub 2008 Dec 6.


B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.

Phan TG, Amesbury M, Gardam S, Crosbie J, Hasbold J, Hodgkin PD, Basten A, Brink R.

J Exp Med. 2003 Apr 7;197(7):845-60. Epub 2003 Mar 31.


A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.

Oishi H, Tsubaki T, Miyazaki T, Ono M, Nose M, Takahashi S.

J Immunol. 2013 Mar 1;190(5):2129-37. doi: 10.4049/jimmunol.1202196. Epub 2013 Jan 30.


Human CD72 splicing isoform responsible for resistance to systemic lupus erythematosus regulates serum immunoglobulin level and is localized in endoplasmic reticulum.

Hitomi Y, Adachi T, Tsuchiya N, Honda Z, Tokunaga K, Tsubata T.

BMC Immunol. 2012 Dec 26;13:72. doi: 10.1186/1471-2172-13-72.


A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.

Vadasz Z, Haj T, Balbir A, Peri R, Rosner I, Slobodin G, Kessel A, Toubi E.

Semin Arthritis Rheum. 2014 Jun;43(6):767-71. doi: 10.1016/j.semarthrit.2013.11.010. Epub 2013 Dec 4.


CD5 maintains tolerance in anergic B cells.

Hippen KL, Tze LE, Behrens TW.

J Exp Med. 2000 Mar 6;191(5):883-90.


Structure and function of CD72 in the non-obese diabetic (NOD) mouse.

Rojas A, Xu F, Rojas M, Thomas JW.

Autoimmunity. 2003 Jun;36(4):233-9.


CD72 negatively regulates signaling through the antigen receptor of B cells.

Adachi T, Wakabayashi C, Nakayama T, Yakura H, Tsubata T.

J Immunol. 2000 Feb 1;164(3):1223-9.


Intact B cell tolerance in the absence of the first component of the classical complement pathway.

Cutler AJ, Cornall RJ, Ferry H, Manderson AP, Botto M, Walport MJ.

Eur J Immunol. 2001 Jul;31(7):2087-93.


Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.

Rathmell JC, Fournier S, Weintraub BC, Allison JP, Goodnow CC.

J Exp Med. 1998 Aug 17;188(4):651-9.


Increased mutations of CD72 transcript in B-lymphocytes from adolescent patients with systemic lupus erythematosus.

Kaneko U, Toyabe S, Hara M, Uchiyama M.

Pediatr Allergy Immunol. 2006 Dec;17(8):565-71.


The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1.

Wu Y, Nadler MJ, Brennan LA, Gish GD, Timms JF, Fusaki N, Jongstra-Bilen J, Tada N, Pawson T, Wither J, Neel BG, Hozumi N.

Curr Biol. 1998 Sep 10;8(18):1009-17.

Supplemental Content

Support Center